Best Borrowers 2008: GlaxoSmithKline

The stars were aligned for GlaxoSmithKline’s $9 billion blockbuster issue, which smashed into the market and took several records with it.

Deutsche Bank
GECC
GlaxoSmithKline
EEB/TGI
Bank of America



If someone were to suggest going to the bond markets for the biggest ever corporate deal outside of the telecoms industry in the midst of the worst financial crisis for decades that is growing almost daily, that person would have been assigned close supervision. If that same person were to propose marketing such a deal with just a single investor conference call, he might well have been forcibly restrained.

Access intelligence that drives action

To unlock this research, enter your email to log in or enquire about access